Skip to main content
Clinical Trials/NCT01438346
NCT01438346
Completed
N/A

A Pilot Study of Two Group-based Intervention Programs for Patients With Substance Abuse Problems

University of Utah2 sites in 1 country38 target enrollmentAugust 2011

Overview

Phase
N/A
Intervention
Not specified
Conditions
Substance-Related Disorders
Sponsor
University of Utah
Enrollment
38
Locations
2
Primary Endpoint
Change from baseline in the measure of the Penn Alcohol and Craving Scale
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This pilot project will evaluate a new mind-body intervention called Mind-Body Bridging (MBB) for reducing substance abuse problems in women who are undergoing a substance abuse treatment program. The main hypothesis is that MBB will be more effective than the control (standard) intervention program in helping people reduce their craving for illicit substances and/or alcohol.

Detailed Description

This is a randomized clinical pilot study in which MBB will be compared with a standard treatment program for substance abuse. Both groups will run concurrently over the course of a 10-week period, twice per week.

Registry
clinicaltrials.gov
Start Date
August 2011
End Date
August 2012
Last Updated
9 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Yoshio Nakamura

Research Assistant Professor

University of Utah

Eligibility Criteria

Inclusion Criteria

  • Substance abuse or dependence
  • Resident/day client in the House of Hope substance abuse treatment program
  • Minimum stay in treatment at House of Hope for 3.5 months
  • Fluent in English

Exclusion Criteria

  • Psychosis
  • Suicide risk
  • Significant withdrawal risk
  • Severe, unstable depression
  • Requires intensive mental health treatment
  • Cognitive impairment

Outcomes

Primary Outcomes

Change from baseline in the measure of the Penn Alcohol and Craving Scale

Time Frame: Week 5 and Week 11

Change from baseline in the extent of drug and alcohol craving at Week 5 and Week 11, as measured by a modified version of the Penn Alcohol and Craving Scale

Change from baseline in Alcohol and Drug Use Consequences Scale

Time Frame: Week 5 and Week 11

Change from baseline in the measure of alcohol and drug consequences at Week 5 and Week 11, as measured by Alcohol and Drug Use Consequences Scale

Secondary Outcomes

  • Sleep(Pre (Baseline) Mid (Week 5), Post (Week 11))
  • Well-being(Weekly for 11 weeks)
  • Self-Compassion(Pre (Baseline) Mid (Week 5), Post (Week 11))
  • Depression(Pre (Baseline) Mid (Week 5), Post (Week 11))
  • Mindfulness(Pre (Baseline) Mid (Week 5), Post (Week 11))
  • Subjective distress(Pre (Baseline) Mid (Week 5), Post (Week 11))

Study Sites (2)

Loading locations...

Similar Trials